Feasibility study of an indirect treatment comparison and population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in women with newly diagnosed advanced ovarian cancer
ONCOLOGY RESEARCH AND TREATMENT（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要